What is ResMed's total equity?

ResMed (RMD) reported total equity of $6.49B in Q1 2026.

How has ResMed's total equity changed year-over-year?

ResMed's total equity increased by 17.1% year-over-year, from $5.55B to $6.49B.

What is the long-term trend for ResMed's total equity?

Over 4 years (2021 to 2025), ResMed's total equity has grown at a 19.9% compound annual growth rate (CAGR), from $2.89B to $5.97B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

ResMed RMD Total Equity

Total Equity at other companies

Eli LillyLLY

$31.2B+97.9%

Five Point Holdings, Inc.FPH

$2.31B+4.2%

Inspire Medical SystemsINSP

$792.34M+24.6%

Viemed Healthcare, Inc.VMD

$143.86M+6.8%

LivaNovaLIVN

$1.21B+17.1%

AdaptHealthAHCO

$1.51B-3.9%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$29.05B-22.6%

Enterprise value$28.5B-23.3%

P/E19.1×-7.7×

P/S5.3×-2.0×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's total equity?: ResMed (RMD) reported total equity of $6.49B in Q1 2026.
How has ResMed's total equity changed year-over-year?: ResMed's total equity increased by 17.1% year-over-year, from $5.55B to $6.49B.
What is the long-term trend for ResMed's total equity?: Over 4 years (2021 to 2025), ResMed's total equity has grown at a 19.9% compound annual growth rate (CAGR), from $2.89B to $5.97B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.